Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 29.06.2007 In consummation of the Sale and Purchase Agreement notified on 22 February 2007, Sartorius AG has this morning acquired the shares held by the founders of French Stedim S.A. for 43 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Preliminary Figures for the First Quarter of 2007 18.04.2007 In the first quarter of fiscal 2007, order intake for the Sartorius Group rose 5.7% (currency-adjusted: +8.5%) to EUR140.2 million ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 23.02.2007 The Supervisory Board and the Executive Board of Sartorius AG have resolved at their meeting today to suggest at the Annual Shareholders Meeting on April 27, 2007, to raise ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 22.02.2007 Sartorius AG, Göttingen, Germany, has entered into a binding agreement with Stedim S.A., Aubagne, France, and its founders. According to this agreement, Sartorius acquires the Stedim ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 25.01.2007 In fiscal 2006, group sales revenue rose 7.6% (currency-adjusted: +8.1%) to EUR521.1 million (2005: EUR484.3 mn). Due to double-digit growth rates in the filter business, the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 17.10.2006 During the first nine months of fiscal 2006, sales revenue of the Sartorius Group rose 9.2% (currency-adjusted: +9.0%) to EUR386.0 million (previous year: EUR353.5 mn). In the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 19.07.2006 During the first half of fiscal 2006, sales revenue of the Sartorius Group rose 10.2% (currency-adjusted: +9.1%) to EUR257.1 million (previous year: EUR233.2 mn). In the Biotechnology ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 20.04.2006 During the first three months of 2006, sales revenue of the Sartorius Group rose 15.1% (currency-adjusted: +12.5%) to EUR128.6 million (Q1 of 2005: EUR111.8 mn). Sales revenue for the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 28.02.2006 The Supervisory Board and the Executive Board of Sartorius AG have resolved at their meeting today to suggest at the Annual Shareholders Meeting on April 26, 2006, to raise ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 02.02.2006 Group earnings (EBIT) improved by 34.3% / Earnings per share up from EUR0.89 to EUR1.30 / Sales revenue up 3.6% / Order intake up 7.7% / Profitable growth expected to be continued in ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 19.10.2005 In the first nine months of fiscal 2005, Group sales revenue rose 4.7% (currency adjusted: +5.6%) to EUR353.5 million (previous year: EUR337.5 mn). Sales revenue for the Biotechnology ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 28.09.2005 As of October 1, 2005, the laboratory and process equipment provider Sartorius will acquire a 100% stake in Omnimark Instrument Corporation based in Tempe, Arizona, USA. Omnimark ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 21.07.2005 Ad hoc Announcement According to Section 15 of the German Securities Trading Act (WpHG) In the first half of fiscal 2005, Group sales revenue rose 4.9% (currency-adjusted: +6.2%) to ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 25.04.2005 In the first quarter of fiscal 2005, Group sales revenue increased by 3.4% (currency adjusted: +4.7%) to EUR111.8 million (previous year: EUR108.1 million). Sales revenue for the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 04.03.2005 The Supervisory Board and the Executive Board of Sartorius AG have resolved at their meeting today to suggest at the Annual Shareholders Meeting on May 12, 2005, to raise dividends ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 21.02.2005 In fiscal 2004, the Sartorius Group more than doubled its earnings before interest and taxes (EBIT) from EUR14.7 million to EUR32.5 million. For the Biotechnology Division, EBIT was ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The Executive Board and the Supervisory Board of Sartorius AG and Vivascience AG decided not to carry out an IPO of Vivascience AG that had originally been planned for 2001 and then postponed ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. In the first nine-month period of 2004, the Sartorius Group increased its sales revenue by 3.9% (currency-adjusted: 6.6%) to 337.5 million from 324.8 million a year ago. We raised sales ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. First-half sales revenue of the Sartorius Group rose 2.5% (currency-adjusted: 5.2%) to EUR222.3 million from EUR217.0 million a year ago. We increased sales revenue for the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The positive earnings development last reported by the Sartorius Group continued in the first quarter of 2004. Earnings before interest, taxes, depreciation and amortization, EBITDA, rose ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The Sartorius Group increased its earnings before interest and taxes (EBIT) in fiscal 2003 by 8.6% to 14.7 million euros (previous year: 13.5 million). The EBITDA (earnings before interest, ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. It was resolved in the Sartorius AG´s Supervisory Board meeting dated December 18th, 2003 to extend the appointment of Dr. Eric Janssens, who is Executive Board Member Biotechnology Division ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. During the first nine months of fiscal 2003, Sartorius Group sales revenue fell 6.5% to 324.8 million euros (previous year: 347.3 million euros). Adjusted for the impact of foreign currencies, ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The executive management of Diessel GmbH & Co. KG in Hildesheim filed a petition today to open insolvency proceedings. B. Braun Biotech International GmbH, a subsidiary of Sartorius AG, is a ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. In the first half of 2003, sales revenue of the Sartorius Group fell 6.7% to 217.0 million euros from 232.6 million euros a year earlier, whereas sales revenue adjusted for the impact of foreign ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Effective June 30 2003, Dr. Ralf Hermann will resign from his position as Chairman of the Executive Board of Vivascience AG, biotech suppliers and proteomics specialists. Dr. Hermann will leave the Executive Board of Vivascience as of 31 December ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Earnings for the first quarter of 2003 developed moderately in line with the decrease in sales revenue development, which was caused by the weak economic activity and the impact of foreign exchange ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. In the 1st quarter of 2003, sales revenue and order intake reported by the biotechnology supplier and mechatronics manufacturer Sartorius declined slightly in comparison to last years quarter. ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. - Sales revenue grew 6.1% to EUR476.5 million - EBITDA rose 7.1% to EUR36.3 million The Sartorius Group increased its earnings before interest, taxes, depreciation and amortization, EBITDA, in ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. At its meeting on November 11, 2002, the Supervisory Board of Sartorius AG unanimously passed a resolution to appoint Dr. Joachim Kreuzburg with immediate effect as a member of the Executive ...